Metraipolis › archive › dc_e5a515cfd484
NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions — Europe PMC PMID:41756289
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41756289
- DOI
- 10.3389/fimmu.2026.1763843
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T22:06:16.128Z
- SHA-256 of the archived text
b8c8fe0a03e41f21cf8ecdb9b67c3cbe49d8a1ddf3fa456698f218f27ab49776- Stable URL of this page
https://metraipolis.com/documento/dc_e5a515cfd484
How to cite
NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions — Europe PMC PMID:41756289 — Europe PMC (en), https://europepmc.org/article/MED/41756289 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5a515cfd484 (Metraipolis archive dc_e5a515cfd484, sha256 b8c8fe0a03e41f21cf8ecdb9b67c3cbe49d8a1ddf3fa456698f218f27ab49776)
BibTeX
@misc{dce5a515cfd484,
title = {NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions — Europe PMC PMID:41756289},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41756289},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5a515cfd484; sha256 b8c8fe0a03e41f21cf8ecdb9b67c3cbe49d8a1ddf3fa456698f218f27ab49776},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756289. Agents can read the archived copy with the MCP tool read_document.